<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy	</title>
	<atom:link href="https://www.novumpr.nl/2019/05/21/first-patient-treated-in-diamond-study-to-evaluate-if-veltassa-patiromer-improves-outcomes-by-enabling-long-term-use-of-essential-raasi-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2019/05/21/first-patient-treated-in-diamond-study-to-evaluate-if-veltassa-patiromer-improves-outcomes-by-enabling-long-term-use-of-essential-raasi-therapy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=first-patient-treated-in-diamond-study-to-evaluate-if-veltassa-patiromer-improves-outcomes-by-enabling-long-term-use-of-essential-raasi-therapy</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Tue, 21 May 2019 06:18:22 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
